FDA Grants Accelerated Approval to Iberdomide Combination for Multiple Myeloma Based on MRD-Negative CR
Oral SERDs in Breast Cancer: Powerful Shift From Rescue to Platform Therapy
Spider-Man: Brand New Day’s Gene-Silencing Technology: Could It Fight Cancer?
Lucy Davis Reveals Incurable Stage 4 Breast Cancer: Diagnosis, Bone Metastases, and What We Know
LITESPARK-011 Trial: Belzutifan Plus Lenvatinib vs Cabozantinib in Advanced RCC
Empowering Oncologists: How to Fight Burnout? Dr. Mimi Knoll
BMS Team Celebrates Accelerated FDA Approval for Multiple Myeloma
GC-OS 2026 to Bring the Global Cardio-Oncology Community to Williamsburg
2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will be held from May 21-22, 2025 at Houston, Texas. The 2025 Hematopoietic Stem Cell and Myelodysplastic Syndromes (MDS) Symposium will bring together global experts to explore the latest advancements in MDS research and treatment. This event focuses on the biological mechanisms of hematopoietic stem cells […]
